By having this discussion, you can feel more confident about your treatment plan
Big Pharma often turns to NFL games to hawk their blockbuster treatments, but drug makers have typically been hesitant to advertise during the big game
Semaglutide remains eligible for compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act when prescribed by a licensed provider and prepared by a licensed pharmacy meeting USP standards
As this debate continues, though, we must recognize the origin of the status quo these restrictions came to be in a cultural and clinical environment surrounding obesity that today is nearly unrecognizable: Obesity is no longer discussed alongside cosmetic conditions as it was in 1990 its a disease we treat
Understanding what is actually happening in your body can make the difference between panicking unnecessarily and knowing exactly when to call your doctor
Research peptides fall into a regulatory grey area in Canada